当前位置: 首页 >> 检索结果
共有 38771 条符合本次的查询结果, 用时 4.8600468 秒

1581. Response.

作者: Bijan Teja.;Nicholas A Bosch.;Allan Walkey.
来源: Chest. 2023年164卷1期e20页

1582. Time Matters When Adding Corticosteroids to Escalating Vasopressors in Septic Shock.

作者: Pablo Jorge-Monjas.;Miguel Bardají-Carrillo.;Mario Lorenzo-López.;Eduardo Tamayo.
来源: Chest. 2023年164卷1期e19-e20页

1583. A 79-Year-Old Woman With Shock.

作者: Cristina Salmon.;Shriya Khurana.;Rodrigo Cavallazzi.
来源: Chest. 2023年164卷1期e15-e17页

1584. Voxelotor as a Treatment of Persistent Hypoxia in the ICU.

作者: Omar Al-Qudsi.;John M Reynolds.;John C Haney.;Ian J Welsby.
来源: Chest. 2023年164卷1期e1-e4页
Hypoxia is encountered frequently in the ICU as a result of a wide range of pathologic characteristics. The oxygen-hemoglobin dissociation curve describes hemoglobin's affinity for a given Po2 and factors affecting uptake and offload. Research in manipulating this relationship between hemoglobin and oxygen is sparing. Voxelotor is a hemoglobin oxygen-affinity modulator that is approved by the US Food and Drug Association for use in the management of sickle cell disease. We present two patients without sickle cell disease who underwent treatment with this novel agent to assist with chronic hypoxia and weaning of mechanical support.

1585. Chest Imaging of COPD: Bridging the COPD Research Gap With Stop, Look, and Listen.

作者: Carrie L Pistenmaa.;George R Washko.
来源: Chest. 2023年164卷1期8-10页

1586. What Can Big Data Teach Us About Air Pollution and Pneumonia?

作者: Coralynn Sack.;Engi F Attia.
来源: Chest. 2023年164卷1期6-7页

1587. Monitoring Biologic Therapy in Asthma Using Functional Imaging.

作者: Sean B Fain.;Alejandro P Comellas.
来源: Chest. 2023年164卷1期3-5页

1588. Corrigendum to: CHEST. 2022;162(5):e207-e243.

来源: Chest. 2023年164卷1期267页

1589. Evolution of the Pulse Ox.

作者: Bennett Yang.;Joel Moss.
来源: Chest. 2023年164卷1期24-26页

1590. Abandon the Acid-Fast Bacilli Smear for Patients With TB on Effective Treatment.

作者: Ryan Cooper.;Margaret Williams.;Kevin P Fennelly.
来源: Chest. 2023年164卷1期21-23页

1591. Disability Rights and Life-Sustaining Treatment: Building Bridges Between Clinicians and Advocates.

作者: Ari Ne'eman.;Erin S DeMartino.
来源: Chest. 2023年164卷1期203-205页

1592. Lung Cancer Screening: Millions of Promises and More Challenges.

作者: Robert Smyth.;Catherine R Sears.
来源: Chest. 2023年164卷1期18-20页

1593. For One Night Only: Are Single-Night Studies Sufficient to Predict Risk of Hypertension in OSA?

作者: Christopher D Turnbull.;Sebastien Bailly.
来源: Chest. 2023年164卷1期15-17页

1594. CHEST Meets Brain: Understanding Chronic Cough Requires Interdisciplinary Thinking.

作者: J Eric Schmitt.
来源: Chest. 2023年164卷1期13-14页

1595. Contamination of Blood Cultures From Indwelling Arterial Catheters in Critically Ill Patients: Alternative Blood Culture Sampling?

作者: Koshi Ota.
来源: Chest. 2023年164卷1期11-12页

1596. A Consistent Vision During Changing Times.

作者: Peter J Mazzone.
来源: Chest. 2023年164卷1期1-2页

1597. CT Scan Differences of Pulmonary TB According to Presence of Pleural Effusion.

作者: Min Kyung Jung.;Sang Young Lee.;Eun Jeong Min.;Jeong Min Ko.
来源: Chest. 2023年164卷6期1387-1395页
Subpleural micronodules and interlobular septal thickening are common CT scan findings in TB pleural effusion. These CT scan features could help us differentiate between TB pleural effusion and nonTB empyema.

1598. The Economic Burden of Bronchiectasis: A Systematic Review.

作者: Jack M Roberts.;Vikas Goyal.;Sanjeewa Kularatna.;Anne B Chang.;Nitin Kapur.;James D Chalmers.;Pieter C Goeminne.;Francisco Hernandez.;Julie M Marchant.;Steven M McPhail.
来源: Chest. 2023年164卷6期1396-1421页
Bronchiectasis, a previously neglected condition, now has renewed research interest. There are a few systematic reviews that have reported on the economic and societal burden of bronchiectasis in adults, but none have reported on children. We undertook this systematic review to estimate the economic burden of bronchiectasis in children and adults.

1599. Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease.

作者: Joong-Yub Kim.;JiWon Park.;Yunhee Choi.;Taek Soo Kim.;Nakwon Kwak.;Jae-Joon Yim.
来源: Chest. 2023年164卷5期1108-1114页
Morbidity and mortality from nontuberculous mycobacterial pulmonary disease (NTM-PD) are increasing. Mycobacterium avium complex (MAC) is the most common cause of NTM-PD. Microbiological outcomes are widely used as the primary end point of antimicrobial treatment, but their long-term impact on prognosis is uncertain.

1600. Diagnostic Impact of a Race-Composite Pulmonary Function Test Results Interpretation Strategy.

作者: Margaret J Connolly.;Patrick A Donohue.;Rohith Palli.;Sandhya Khurana.;Xueya Cai.;Steve N Georas.
来源: Chest. 2023年164卷5期1290-1295页
共有 38771 条符合本次的查询结果, 用时 4.8600468 秒